A new research report on the extremity reconstruction market in the U.S. has been added to the repository of MarketResearchReports.biz. The market study, titled “Extremity Reconstruction - US Analysis And Market Forecasts,” offers a complete overview of this market on the basis of its current as well as historical performance.
According to the research study, the U.S. extremity reconstruction market stood at US$882.6 mn in 2014. Analysts expect this market to reach a value of US$1.3 bn by the end of 2021. The rapid rise in the geriatric population, coupled with the increasing prevalence of chronic diseases such as arthritis, osteoporosis, and osteoarthritis, is the key factor behind the rise of the market for extremity reconstruction in the U.S.
In addition to this, the growing preference for an active lifestyle among U.S. citizens and continuous efforts of market participants to educate medical and healthcare professionals as well as patients regarding extremity implants in order to promote their products are likely to propel the U.S. extremity reconstruction market over the next few years, states the research report.
The study further states that the U.S. market for extremity reconstruction will also benefit from favorable reimbursement policies and the increasing incidence of joint issues in this country.
Shoulder implant devices, elbow implant devices, wrist implant devices, digits implant devices, and ankle joints implant devices are the major implant devices utilized in the U.S. extremity reconstruction market. The demand for shoulder implant devices is the highest in the global arena, owing to the high prevalence of shoulder injuries as well as age-related shoulder arthritis, notes the market study.
The research report also discusses the U.S. extremity reconstruction market with respect to its share in the global market for extremity reconstruction. According to the report, the U.S. dominated the overall market in 2014 with a share of 76.2%. The U.S. extremity reconstruction market is likely to retain its position in the coming years and is expected to account for a share of around 78% in the global market by the end of 2021.
The main objective of this study is to present a clear picture of the U.S. extremity reconstruction market and assists market participants in making crucial strategies for the further expansion of their businesses. It analyzes the competitive landscape of the U.S. market for extremity reconstruction by evaluating the profiles of key companies in this market.
As per the study, Stryker, Kyocera Medical Corp., Integra LifeSciences, DJO Global, Corin Group, Tornier, Acumed, Wright Medical Group, Zimmer Biomet Holdings, Exactech, DePuy Synthes, Smith & Nephew, Lima Corporate, and Arthrex are some of the major organization functioning in the U.S. extremity reconstruction market.
To order report Call Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org